Harmonizing antibiotic regimens with renal replacement therapy

被引:5
作者
Jang, Soo Min [1 ]
Lewis, Susan J. [2 ]
Mueller, Bruce A. [3 ]
机构
[1] Loma Linda Univ, Dept Pharm Practice, Sch Pharm, Loma Linda, CA 92350 USA
[2] Univ Findlay, Dept Pharm Practice, Coll Pharm, Findlay, OH USA
[3] Michigan Coll Pharm, Clin Pharm Dept, Ann Arbor, MI USA
关键词
Renal replacement therapy; acute kidney injury; antibiotics; pharmacokinetics; pharmacodynamics; CRITICALLY-ILL PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; GENTAMICIN PHARMACOKINETICS; POPULATION PHARMACOKINETICS; VANCOMYCIN EXPOSURE; INTERMITTENT; PHARMACODYNAMICS; GUIDELINES; MEROPENEM; PIPERACILLIN;
D O I
10.1080/14787210.2020.1764845
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Critically ill patients with acute kidney injury often require renal replacement therapy and antibiotic therapy. Mortality rates are high in these patients, possibly due to ineffective dosing due to altered pharmacokinetic profiles and drug removal by renal replacement therapy. Areas covered: The main types of renal replacement therapies are intermittent hemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement therapy. Each of these renal replacement therapies may have drastic, yet different, effects on antibiotic serum concentration profiles. Moreover, three antibiotic administration strategies are often used: (1) standard infusion; (2) extended infusion; and (3) continuous infusion. A literature review was conducted on Medline in December 2019 to identify pertinent research. Expert opinion: Renal replacement therapies used in the treatment of acute kidney injury in critically ill patients usually complicates antibiotic use. Although antibiotic toxicity can be seen, most studies find that these patients do not receive sufficient antibiotic doses to achieve desired pharmacodynamic targets. Clinicians should dose antibiotics to match renal replacement therapy drug clearance characteristics to antibiotic pharmacodynamic profiles.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 52 条
[1]   Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion [J].
Adembri, Chiara ;
Fallani, Stefania ;
Cassetta, Maria Iris ;
Arrigucci, Silvia ;
Ottaviano, Alessandra ;
Pecile, Patrizia ;
Mazzei, Teresita ;
De Gaudio, Raffaele ;
Novelli, Andrea .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) :122-129
[2]   Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial [J].
Barbar, Saber Davide ;
Binquet, Christine ;
Monchi, Mehran ;
Bruyere, Remi ;
Quenot, Jean-Pierre .
TRIALS, 2014, 15
[3]   Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy [J].
Bue, Mats ;
Sou, Tomas ;
Okkels, Anna Sophie L. ;
Hanberg, Pelle ;
Thorsted, Anders ;
Friberg, Lena E. ;
Andersson, Torben L. ;
Obrink-Hansen, Kristina ;
Christensen, Steffen .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 92 :133-140
[4]   Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis [J].
Burkhardt, Olaf ;
Joukhadar, Christian ;
Traunmueller, Friederike ;
Hadem, Johannes ;
Welte, Tobias ;
Kielstein, Jan T. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (01) :224-225
[5]   Principles of antibacterial dosing in continuous renal replacement therapy [J].
Choi, Gordon ;
Gomersall, Charles D. ;
Tian, Qi ;
Joynt, Gavin M. ;
Freebairn, Ross ;
Lipman, Jeffrey .
CRITICAL CARE MEDICINE, 2009, 37 (07) :2268-2282
[6]   PHARMACOKINETICS OF MEROPENEM IN SUBJECTS WITH VARIOUS DEGREES OF RENAL IMPAIRMENT [J].
CHRISTENSSON, BA ;
NILSSONEHLE, I ;
HUTCHISON, M ;
HAWORTH, SJ ;
OQVIST, B ;
NORRBY, SR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1532-1537
[7]  
Clark WR, 1997, J AM SOC NEPHROL, V8, P804
[8]   Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis [J].
Claure-Del Gramdo, Rolando ;
Macedo, Etienne ;
Chertow, Glenn M. ;
Soroko, Sharon ;
Himmelfarb, Jonathan ;
Ikizler, T. Alp ;
Paganini, Emil P. ;
Mehta, Ravindra L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (03) :467-475
[9]  
Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63
[10]   Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug' [J].
Drusano, GL .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (04) :289-300